SEC Form 4 · accession 0001209191-16-109143
Atara Biotherapeutics, Inc. · ATRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Dobmeier
Director
Period of report
Mar 17, 2016
Accepted (ET)
Mar 17, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2016 | P | 3,000 | $13.855 | A | 5,500 | D |
Table II — derivative securities
No Table II lines on this filing.